Yujuan Liu

6PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 13, 2024
The Value of Chemokine and Chemokine Receptors in Diagnosis, Prognosis, and Immunotherapy of Hepatocellular Carcinoma.

Zhengyi Wu, Liang Sun, Yongkang Xu

|Feb 13, 2024
Everolimus inhibits hepatoblastoma by inducing autophagy-dependent ferroptosis.

Haijin Huang, Jinlong Yan, Xianyun Xu

|Jan 31, 2024
Enhanced Antipediatric Sarcoma Effect of Everolimus with Secukinumab by Targeting IL17A.

Dan Huang, Zhipeng Wu, Zhengyi Wu

|Jun 23, 2022
Targeting RPL23 restores chemosensitivity of cisplatin-resistant ovarian carcinoma by inhibiting EMT.

Yujuan Liu, Shuhui Lai, Jie He

|Dec 07, 2021
USP1 Promotes GC Metastasis via Stabilizing ID2.

Nuoya Li, Lei Wu, Xingye Zuo

|Mar 24, 2021
Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression.

Shouhua Zhang, Nuoya Li, Yanling Sheng

Pageof 1

Frequent Collaborators

1 joint publications

Yanling Sheng

1 joint publications

Dan Huang

1 joint publications

Zhipeng Wu

1 joint publications

Zhengyi Wu